Overview
Antonio Tomarchio is Founder, Chief Strategy Officer and Chairman at Fantix[1], a position held since June 2024[4]. Tomarchio is an entrepreneur and investor with stakes in over two dozen companies across generative and agentic AI, fintech, tokenization of real world assets and deep tech for advanced materials[2]. Beyond Fantix, Tomarchio serves as Solo GP at Atom Expeditions since August 2022[7], Executive Chair and Investor at Ulysses Medical Technology since January 2022[9], Founding Partner and Investor at Lympha since March 2023[8], and Early Stage Investor and Strategic Advisor at Scalestack since August 2023[6]. Tomarchio is also building the Life360 AI-driven Ads Platform as of March 2025[3] and has been an early stage investor at TrueLayer since September 2016[10]. Tomarchio studied engineering at Politecnico di Milano from 2001 to 2007[11] and completed an Ingénieur degree in Engineering at Ecole Centrale Paris from 2003 to 2005[12].
Profile introduction
Entrepreneur and investor with successful exits and current stakes in over 2 dozen companies across generative and agentic AI, fintech, tokenization of real world assets and deep tech for advanced materials.
Career history
- Building the Life360 AI-driven Ads PlatformMar 2025 to presentLife360
- Founder, Chief Strategy Officer and ChairmanJun 2024 to presentFantix
- Executive Chair, CEO and FounderSep 2022 to Jun 2024Fantix
- Early Stage Investor and Strategic Advisor at ScalestackAug 2023 to presentScalestack
- Solo GPAug 2022 to presentAtom Expeditions
- Founding Partner and InvestorMar 2023 to presentLympha
- Executive Chair and InvestorJan 2022 to presentUlysses Medical Technology
- Early Stage InvestorSep 2016 to presentTrueLayer
Education
- Politecnico di Milano2001 - 2007
- Ingenieur, Engineering at Ecole Centrale Paris2003 - 2005
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.